1
/
of
1
Elabscience
SKU:E-CL-H1203
Human MYD88(Myeloid Differentiation Factor 88) CLIA Kit
Human MYD88(Myeloid Differentiation Factor 88) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The Human MYD88 (Myeloid Differentiation Factor 88) CLIA Kit is a highly advanced and reliable diagnostic tool designed for the accurate detection and quantification of MYD88 in human samples. This cutting-edge kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, which ensures exceptional sensitivity and specificity in detecting MYD88.
The MYD88 protein plays a crucial role in the innate immune response by mediating the signaling pathway of Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). Dysregulation of MYD88 has been implicated in various diseases, including autoimmune disorders and certain types of cancer. Therefore, the precise measurement of MYD88 levels is of paramount importance in clinical research and diagnosis.
The Human MYD88 CLIA Kit offers several key advantages. Firstly, it provides a wide dynamic range, allowing for the accurate quantification of MYD88 in a broad concentration range. Additionally, the kit exhibits excellent reproducibility and precision, ensuring consistent and reliable results. Furthermore, the kit is user-friendly, with a straightforward protocol that can be easily followed by laboratory personnel.
In conclusion, the Human MYD88 CLIA Kit is an indispensable tool for researchers and clinicians involved in the study and diagnosis of diseases associated with MYD88 dysregulation. Its exceptional sensitivity, specificity, and ease of use make it an invaluable asset in the field of molecular diagnostics.
The MYD88 protein plays a crucial role in the innate immune response by mediating the signaling pathway of Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). Dysregulation of MYD88 has been implicated in various diseases, including autoimmune disorders and certain types of cancer. Therefore, the precise measurement of MYD88 levels is of paramount importance in clinical research and diagnosis.
The Human MYD88 CLIA Kit offers several key advantages. Firstly, it provides a wide dynamic range, allowing for the accurate quantification of MYD88 in a broad concentration range. Additionally, the kit exhibits excellent reproducibility and precision, ensuring consistent and reliable results. Furthermore, the kit is user-friendly, with a straightforward protocol that can be easily followed by laboratory personnel.
In conclusion, the Human MYD88 CLIA Kit is an indispensable tool for researchers and clinicians involved in the study and diagnosis of diseases associated with MYD88 dysregulation. Its exceptional sensitivity, specificity, and ease of use make it an invaluable asset in the field of molecular diagnostics.
Share
